Matches in SemOpenAlex for { <https://semopenalex.org/work/W1991448345> ?p ?o ?g. }
Showing items 1 to 79 of
79
with 100 items per page.
- W1991448345 endingPage "199" @default.
- W1991448345 startingPage "199" @default.
- W1991448345 abstract "PET studies were performed to investigate the effects of a new cathechol-O-methyltransferase (COMT) inhibitor, nitecapone (OR-462 [3-(3,4-dihydroxy-5-nitrobenzylidene)- 2,4-pentadione]), on the accumulation of dopamine in the striatum and whether it is able to improve [18F]6-fluorodopa imaging of the brain. Altogether, three patients with Parkinson's disease (PD) and three normal volunteers were examined, first without nitecapone and then with an oral dose of 100 mg of nitecapone 1 hour before the IV injection of 3 mCi of [18F]6-fluorodopa. High-pressure liquid chromatography analysis of arterial plasma samples showed a significant reduction in the metabolic conversion rate from [18F]6-fluorodopa to [18F]3-O-methylfluorodopa after the administration of nitecapone. PET studies showed that nitecapone significantly (p less than 0.05) increased the [18F]6-fluorodopa accumulation in the striatum both in PD patients and normal controls; the magnitude of this increase was 20.0 +/- 5.5% (mean +/- SEM). The ratio of radioactivity in the striatum and arterial plasma was increased 39.0 +/- 5.0% (mean +/- SEM) after the administration of nitecapone. Consequently, the quality of PET images after OR-462 was better, which has implications for future [18F]6-fluorodopa studies. In addition, COMT inhibition may have clinical advantages by improving levodopa treatment in PD." @default.
- W1991448345 created "2016-06-24" @default.
- W1991448345 creator A5004643649 @default.
- W1991448345 creator A5011636993 @default.
- W1991448345 creator A5049804910 @default.
- W1991448345 creator A5061657577 @default.
- W1991448345 creator A5061737582 @default.
- W1991448345 creator A5068747498 @default.
- W1991448345 creator A5073669688 @default.
- W1991448345 date "1992-01-01" @default.
- W1991448345 modified "2023-09-23" @default.
- W1991448345 title "[<sup>18</sup>F]‐6‐Fluorodopa PET scanning in Parkinson's disease after selective COMT inhibition with nitecapone (OR‐462)" @default.
- W1991448345 doi "https://doi.org/10.1212/wnl.42.1.199" @default.
- W1991448345 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1734304" @default.
- W1991448345 hasPublicationYear "1992" @default.
- W1991448345 type Work @default.
- W1991448345 sameAs 1991448345 @default.
- W1991448345 citedByCount "44" @default.
- W1991448345 countsByYear W19914483452013 @default.
- W1991448345 countsByYear W19914483452016 @default.
- W1991448345 countsByYear W19914483452019 @default.
- W1991448345 crossrefType "journal-article" @default.
- W1991448345 hasAuthorship W1991448345A5004643649 @default.
- W1991448345 hasAuthorship W1991448345A5011636993 @default.
- W1991448345 hasAuthorship W1991448345A5049804910 @default.
- W1991448345 hasAuthorship W1991448345A5061657577 @default.
- W1991448345 hasAuthorship W1991448345A5061737582 @default.
- W1991448345 hasAuthorship W1991448345A5068747498 @default.
- W1991448345 hasAuthorship W1991448345A5073669688 @default.
- W1991448345 hasConcept C104317684 @default.
- W1991448345 hasConcept C126322002 @default.
- W1991448345 hasConcept C15744967 @default.
- W1991448345 hasConcept C180754005 @default.
- W1991448345 hasConcept C185361966 @default.
- W1991448345 hasConcept C185592680 @default.
- W1991448345 hasConcept C2779134260 @default.
- W1991448345 hasConcept C2779734285 @default.
- W1991448345 hasConcept C2780062018 @default.
- W1991448345 hasConcept C2780304432 @default.
- W1991448345 hasConcept C2989005 @default.
- W1991448345 hasConcept C513476851 @default.
- W1991448345 hasConcept C55493867 @default.
- W1991448345 hasConcept C71924100 @default.
- W1991448345 hasConceptScore W1991448345C104317684 @default.
- W1991448345 hasConceptScore W1991448345C126322002 @default.
- W1991448345 hasConceptScore W1991448345C15744967 @default.
- W1991448345 hasConceptScore W1991448345C180754005 @default.
- W1991448345 hasConceptScore W1991448345C185361966 @default.
- W1991448345 hasConceptScore W1991448345C185592680 @default.
- W1991448345 hasConceptScore W1991448345C2779134260 @default.
- W1991448345 hasConceptScore W1991448345C2779734285 @default.
- W1991448345 hasConceptScore W1991448345C2780062018 @default.
- W1991448345 hasConceptScore W1991448345C2780304432 @default.
- W1991448345 hasConceptScore W1991448345C2989005 @default.
- W1991448345 hasConceptScore W1991448345C513476851 @default.
- W1991448345 hasConceptScore W1991448345C55493867 @default.
- W1991448345 hasConceptScore W1991448345C71924100 @default.
- W1991448345 hasIssue "1" @default.
- W1991448345 hasLocation W19914483451 @default.
- W1991448345 hasLocation W19914483452 @default.
- W1991448345 hasOpenAccess W1991448345 @default.
- W1991448345 hasPrimaryLocation W19914483451 @default.
- W1991448345 hasRelatedWork W162107846 @default.
- W1991448345 hasRelatedWork W2062206617 @default.
- W1991448345 hasRelatedWork W2073655734 @default.
- W1991448345 hasRelatedWork W2151204406 @default.
- W1991448345 hasRelatedWork W2156186003 @default.
- W1991448345 hasRelatedWork W2201619946 @default.
- W1991448345 hasRelatedWork W2351945456 @default.
- W1991448345 hasRelatedWork W2378738157 @default.
- W1991448345 hasRelatedWork W2516291096 @default.
- W1991448345 hasRelatedWork W2982184566 @default.
- W1991448345 hasVolume "42" @default.
- W1991448345 isParatext "false" @default.
- W1991448345 isRetracted "false" @default.
- W1991448345 magId "1991448345" @default.
- W1991448345 workType "article" @default.